CANNAINVESTOR Magazine March / April 2017 - Page 53


One author labeled the 100 years between 1837 and 1937 as the Golden Age of Medical Cannabis. During that time, it was a common medical ingredient in a wide variety of commercially available pharmaceutical treatments. In fact, one museum has identified more than 600 medical products involving cannabis as a chief ingredient prior to its prohibition in 1937.

For more on the above timeline and information:

In 2012, the European Coalition for Just and Effective Drug Policies (ENCOD) produced its report “700 MEDICINAL USES OF CANNABIS SORTED BY DISEASE”. ENCOD provides many vetted links sorted by disease and is described as “a collection of clinical studies, papers and references providing the ultimate resource for medical disorders helped by medical marijuana”. ENCOD 700 uses

In the UK, a March article noted that “researchers believe the drug can help control epileptic seizures, slow the progression of Alzheimer’s disease, and stop some cancers from spreading”. This is a particularly good reference as it is also used for the animal care sector section above. Oxford University announced a $12.36 million-dollar program on March 17th that it “hopes to help develop new therapies for acute and chronic conditions by examining the effects of medical cannabis”. OXFORD. Also in March, the results of a clinical trial in Mexico for children with epilepsy concluded “the results of this study are very exciting as they show the best results of any product/medication ever recorded regarding the reduction of seizures in Lennox-Gastaut Syndrome patients, with 17% of patients in the study experiencing 100 percent relief from their seizures.”

Mexico Study Results And what about Jamaican scientists reported to be creating a low cost cannabis derived drug for Hepatitis-C? hepatitis-c